Valuation (53%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 16.60 | 38.78 |
| PEG Ratio (TTM) | 2.89 | 108.19 |
| P/S Ratio (TTM) | 1.26 | 2.82 |
| P/B Ratio (TTM) | 14.07 | 10.35 |
| P/FCF Ratio (TTM) | 9.80 | 27.60 |
| Price to 5YR AVG Earnings Ratio | -941.81 | 11.36 |
| Price to 5YR AVG FCF Ratio | 26.62 | 17.60 |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 7.96% | 5.56% |
| ROE (TTM) | 73.83% | 26.57% |
| Net Profit Margin (TTM) | 7.27% | 9.24% |
| ROIC 5YR AVG | 11.10% | 18.32% |
Growth (52%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.16% | 23.37% | -57.46% |
| Revenue | -1.25% | 5.00% | 6.94% |
| Net Income | 0.48% | 7.07% | -63.01% |
| Cash Flow | 34.26% | 146.78% | 183.99% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.50 | 1.47 |
| Quick Ratio (TTM) | 1.39 | 1.08 |
| D/E Ratio (TTM) | 6.89 | 2.30 |
| Interest Coverage (TTM) | 3.61 | 5.80 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 3.06 | 3.27 |
| LTL to 5YR AVG FCF | 12.99 | 3.54 |
| Shares Outstanding Growth 5YR AVG | 5.15% | -1.04% |